In recent years major research studies have linked the anti-nausea drug, Zofran, to congenital heart defects. Almost two million birth records from Denmark and Sweden were reviewed by researchers who found babies exposed to the drug during their first trimester more than doubled their risk of “cardiac septal defects,” according to the global news site […]
In recent years major research studies have linked the anti-nausea drug, Zofran, to congenital heart defects. Almost two million birth records from Denmark and Sweden were reviewed by researchers who found babies exposed to the drug during their first trimester more than doubled their risk of “cardiac septal defects,” according to the global news site Digitaljournal.com.
Today many of the mothers affected, who were prescribed Zofran as an “off-label” treatment to their morning sickness, have filed birth injury lawsuits against the drug’s pharmaceutical company, GlaxoSmithKline. Reports indicate there are currently 34 individual motions filed in federal courts.
One Ohio law firm, Monheit Law, has started the website Zofranlegal.com where this particular case, among others, is made public. Potentially, it could lead an alliance of sorts with other lawsuits and even the filing of a class-action lawsuit.
One of the claims filed in late July represented by Monheit is from a Cleveland-area mother who says the drug use during her pregnancy about 10 years ago caused her unborn child to develop a “large atrial septal defect.” She was prescribed the drug after seeing her OB/GYN for the nausea and vomiting caused by morning sickness.
When she gave birth to her daughter in January of 1995 the baby immediately faced a variety of lung-related issues, including pneumonia, that forced her to spend the first nine days of her life in the neonatal intensive care unit (NICU).
The respiratory issues persisted over the next couple of years, and by age two she was diagnosed with a congenital heart defect identified as a large atrial septal defect (ASD). Doctors also determined that her daughter’s lungs had been damaged by the conditions effect on her blood flow.
After open-heart surgery at the age of three, continual treatment, and regular monitoring, her daughter’s condition has improved greatly to the point that doctors determined her atrial defect had “completely mended.” Unfortunately, as the claim points out, she still suffers from allergies, asthma, and related breathing problems her mother believes to be associated with her original ailment.
Any women who were irresponsibly prescribed Zofran during pregnancy for their morning sickness are encouraged to seek a free consultation and decide if their situation demands legal action, according to Zofranlegal.com.
When you're looking for one spot to keep up on the most recent news of the day, look no further than Daily Inbox. Our group of professional researchers and writers work together to bring you the best information across a variety of topics from fashion to business, and everything in between.
Copyright 2014 DailyInbox.com